AGILENT TECHNOLOGIES, INC. vs AMETEK, Inc., two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where A and AME diverge most: on debt / equity, A reads 0.54 and AME reads 0.18; on dividend yield, A reads 0.6% and AME reads 0.2%. The rest of the comparable metrics sit closer together. What AME's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | A | AME |
|---|---|---|
| Price | $170.59 | $248.36 |
| Market cap | $48.3B | $57.1B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Mature | Growth |
| P/E | 33.6 | 36.3 |
| P/B | 6.56 | 5.07 |
| P/S | 6.55 | 7.26 |
| EV/EBITDA | 28.5 | 23.9 |
| Revenue growth | +8.6% | +12.6% |
| Operating margin | 23.6% | 25.8% |
| Net margin | 19.5% | 20.0% |
| Return on equity | 19.6% | 14.0% |
| Return on assets | 10.3% | 9.5% |
| Return on invested capital | 11.8% | 12.7% |
| FCF yield | 2.6% | 3.2% |
| Dividend yield | 0.6% | 0.2% |
| Debt / equity | 0.54 | 0.18 |
| Current ratio | 2.05 | 1.21 |
| Altman Z (solvency) | 5.42 | 7.71 |
| Piotroski F (quality) | 5 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.